Remove topics vital-pharmaceuticals
article thumbnail

Balancing Innovation: India’s Views for Pharmaceuticals in the Efta Trade Deal

IIPRD

[iii] Understanding the intricacies of the negotiations thus, becomes even more critical when we consider the actualities of the pharmaceutical industry. The implementation of TRIPS-Plus provisions can also readily facilitate the emergence of monopoly power for brand-name pharmaceutical companies. [v]

article thumbnail

Webinar on ‘Trade Secret and Access to Medicine’ by CUSAT and TWN [September22]

SpicyIP

The pharmaceutical sector is one such industry where trade secrets have been used to veil information which is vital to the general public. However, trade secrets though being considered as an IP does not fulfill some of these objectives. Levine, Elon University School of Law: Trade Secrets and Public Policy.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Current or Ongoing? An Interesting Trend in Intellectual Property News

IPilogue

As I searched for a topic for this blog post, I encountered a common theme: the Canadian technology sector is constantly asking for more action from the Canadian government aimed at fostering innovation in the community. The Pharmaceutical Sector. Photo by Marvin Meyer ( Unsplash ). Research & Development (R&D).

article thumbnail

Working with a Vendor for Better Dataset Solutions

Velocity of Content

Efficiency is vital for data science teams working to complete time-sensitive projects. For example, if a client needs to track unsanctioned import/export of pharmaceuticals across borders, a deep search solution can provide the necessary insights. Another example could be when the data you need is time-bound or transient.

article thumbnail

IP Rights, Access, and WHO’s Pandemic Accord

SpicyIP

However, during discussions, these two topics have been the main points of disagreement. ” Nevertheless, the pharmaceutical sector is adamantly against an IP waiver , claiming that by discouraging innovation, it would impede future pandemic responses. Given this, having an alternative mechanism is vital.

IP 59
article thumbnail

After Granting Certiorari In Enablement Case, Supreme Court Declines Opportunity To Address Written Description

Patently-O

The scope afforded to chemical genus claims under 35 USC § 112(a)’s enablement and written description requirements has been hot topic recently (at least in certain quarters). Novartis Pharmaceuticals Corp., See, for example, Ajinomoto Co. Int’l Trade Comm’n , 932 F.3d 3d 1342 (Fed. 2019); Bayer Healthcare LLC v. Baxalta Inc. ,

article thumbnail

SpicyIP Weekly Review (February 05- February 11)

SpicyIP

Last week we published 9 posts on topics such as our comments on the proposed Trademarks (1st Amendment) Rules, the Madras High Court’s decision with respect to patentability of business methods, and Union Minister of State for Commerce’s response on ability of the current IPR regime to cater concerns arising out of AI generated work.

Trademark 103